pSivida Receives CRL from FDA for ILUVIEN
October 18, 2013 at 06:34 AM EDT
pSivida Corp. (NASDAQ: PSDV ) today announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and
